News
Thermo Fisher Scientific's $13.6 Billion Acquisition of Life Technologies Boosts Flagging M&A Numbers May 01, 2013 | Press Release
Burrill Securities Launches Institutional Breakthrough Series April 29, 2013 | Press Release
Big Biotech Outpaces Big Pharma, Burrill & Company says April 16, 2013 | Press Release
See all News
Thermo Fisher Scientific's $13.6 Billion Acquisition of Life Technologies Boosts Flagging M&A Numbers
May 01, 2013
Cordis Acquires Flexible Stenting Solutions, a Burrill Capital Fund IV Portfolio Company
March 18, 2013
Burrill Securities Acts as Exclusive Placement Agent for EntreMed $10.7 Million Registered Direct
March 01, 2013
Burrill Securities Continues Expansion of Its Investment Banking Activities with Addition of Andrew Daniels
February 04, 2013
Storied Life Sciences Investment Bankers Frederick Frank and Mary Tanner join Burrill & Company
January 07, 2013
Burrill & Company Strengthens Investment Banking Team to Expand Services for Leading Life Sciences Companies
November 05, 2012
Public Equity Life Sciences Financings Show Strength in October, says Burrill & Company
November 01, 2012
Recent Therapeutics IPOs Outperform Market, But Life Sciences Offerings a Mixed Bag, Burrill & Company Reports
September 04, 2012
Burrill & Company Launches Investment Research with Addition of Respected Team of Analysts
August 01, 2012
U.S. Supreme Court Upholds Healthcare Reform
Individual Mandate Ruled Constitutional as a Tax
June 28, 2012
Burrill & Company Names David Wetherell, President and COO of Burrill’s Healthcare Venture
June 26, 2012
Pharmaceutical Companies’ Partnering Activity with Academia, Non-Profits, Governments Picks up in May
June 01, 2012
Burrill & Company Leads $16.5 Million Round in WaveTec Vision to Commercialize Its Cataract Surgery Breakthrough
April 16, 2012
Government, Academics, and VCs Come Together to Fund Translational and Early-Stage Development
March 30, 2012
Burrill & Company Advises Aldagen, Inc. in Sale of its Next Generation Cell Therapy to Cytomedix, Inc.
February 21, 2012
Burrill & Company Advises Samsung in Biosimilars Joint Venture Agreement with Biogen Idec
December 06, 2011
Biotech Visionary G. Steven Burrill Honored With Breath of Life Award From the Northern California Chapter of the Cystic Fibrosis Foundation
November 14, 2011
Debt Worries, Political Dysfunction Take a Toll on Biotech in Third Quarter
Biotech stocks fall with the market as financing activity slows
October 03, 2011
Promise of Personalized Medicine Remains Unrealized
Burrill & Company Meeting Explores the Challenges Faced by the Drugs, Tools, and Diagnostics Companies Leading a Revolution in Healthcare
September 15, 2011
Volatile Markets in August Take a Toll on Life Sciences IPOs
Burrill & Company says poor performance for new issues, depressed stocks, could fuel surge in M&A
August 31, 2011
New Drug Approvals in 2011 Already Match 2010 Total
Burrill & Company sees environment improving for life sciences, but macroeconomic threats persist.
July 31, 2011
Burrill & Company Appoints New Head of Its Merchant Banking Group and Augments Its Group
June 06, 2011
Meet Top Biotech Executives at The Burrill Latin America Life Sciences, May 19-20 in Rio
May 17, 2011
M&A Has Failed to Build Value for Pharma, Burrill Annual Biotech Report Finds
Pressure to Find Better Models to Discover and Develop New Drugs Increases
April 12, 2011
G. Steven Burill Discusses His New Book Biotech 2011-Life Sciences: Looking Back to See Ahead
March 24, 2011
Boom Times for Genomics Startups
Investment is picking up as sales of gene sequencing machines surge
March 17, 2011
Dirk Lammerts joins Burrill Venture Capital Group
Focus will be on building the company’s activities in digital health
March 10, 2011
Burrill & Company and Infinity Group Form Joint Venture Focusing on Life Science Opportunities in China
October 12, 2010
Executive Mindshare Announces New Social Media Platform for Vertical Business Networks
September 15, 2010
Biotech posts strong first quarter gain
Industry benefits from healthcare reform and robust general markets
April 01, 2010
Burrill & Company and WR Hambrecht + Co to collaborate on OpenIPO® transactions
Joint venture will focus on select healthcare companies
October 09, 2009
FDA Commissioner Dr. Margaret Hamburg headlines at the Burrill Annual Personalized Medicine Meeting
September 16, 2009
NewBridge Pharmaceuticals Announces Licensing of Pylera® for Middle East, Africa, Turkey & Caspian Region
July 22, 2009
Burrill Merchant Banking Advises Adlyfe on Alzheimer’s Biomarker Partnership with Wyeth
March 17, 2009
Biotech Industry Turns a Profit for the First Time, But Milestone Overshadowed as Companies Struggle for Survival, Report Finds
February 25, 2009
Burrill Merchant Banking advises Mitsubishi Tanabe Pharma Corporation on transactions with Cytochroma Inc.
September 08, 2008
Biotech red hot in July as potential blockbuster M&A deals awake investors from their summer slumber
August 01, 2008
Burrill Merchant Banking Advises QLT USA on divestment of QLT USA, INC.'s Generic Dermatology and Manufacturing Business
April 12, 2007
Hal Gerber, M.D Joins Burrill & Company’s Merchant Banking Group To Further Expand M&A Services
August 01, 2005
Biotech Recognized as One of San Francisco Mayor Gavin Newsom's First Year Accomplishments
January 07, 2005
Burrill & Company's Merchant Banking Practice Announces Increasing Spin-Out Activity From Pharmaceutical Companies
January 07, 2005
Burrill & Company Announces Promotions and Organizational Changes to Reflect the Growth of its Business
January 05, 2005
G. Steven Burrill is Recognized as Biotech Investment Visionary by Scientific American
November 20, 2002